Tag ~omics

Tag descriptions coming soon to Wherrelz News!


ZeroFox acquires dark web threat intelligence company Vigilante

Maolac pours new funding into superfood mimicking breast milk health benefits

Valar Atomics comes out of stealth with 19M and a pilot reactor site

Keith Murphy: We Believe We are Discovering the Next Step in Drug Development

Tia Health gets over 24 million to build a network of holistic health clinics and virtual services for women

Applied Proteomics Inc Market Insights and Trends To 2022 With Emerging Developments

With 1M in funding Phase Genomics looks to crack genetic codes and discover unknown bacteria

Triomics raises 15M Series A to automate cancer clinical trials matching

Meatable sinks its teeth into 35M to accelerate launch of its cultivated pork products

US Treasury Secretary Janet Yellen pushes for stablecoin regulation by end of year

Global Pharmacogenomics PGx Market Size by Players By Applications Types 2024 Forecast Report

Genetics testing startup Nucleus Genomics criticized for its embryo product: Makes me so nauseous

Will a weaker euro lead to greater US investment in European startups

What tech gets right about healthcare

Peer Medical allows lung cancer patients to anonymously share treatments with each other

New telemedicine service The Cusp rolls out athome hormone test for women to predict menopause

UK biotech startup Mogrify injects 16M to get novel cell therapies to market soon

Sano Genetics a startup helping with Long Covid research raises 25M in seed funding

Agrigenomics Market 2018 Global Analysis Opportunities and Forecast To 2023

Verily Alphabets other moneymaking nonGoogle business partners with Color on genetic analysis

Proteomics Market Size Share: Industry Forecast 2022

Proteomics Market Advance Technology Research Key Manufacturers Competitive Analysis and Development Forecasts

One way to grow Seattles biotech economy: Start small

Companies tracking mutations in cancer cells can provide a key to unlocking better therapies

The genomicsfocused Illumina Accelerator backs five new companies

125 million for Inscripta may usher in the next wave of genetic engineering

GeekWire Calender Picks: Hacking education comic books artificial intelligence and robotics

With 8M seed round Protai leverages the proteome to speed up drug discovery

Proteomics Market Leads to generate more revenue in coming years till 2025 With Benefit from Experimenting with Current Technology

informed you want to be Trio of European media veterans take on the problem of news economics

Softwares meteoric rise: Have VCs gone too far

Genomics Market Assisting Biotechnology and Agriculture Sector to Generate Better Revenue

Stratos Genomics raises 20M to commercialize fast DNA sequencing technology

Phase Genomics lands 39M in grants to improve testing for chromosomal abnormalities

Men are a niche demographic

DeepMind claims early progress in AIbased predictive protein modelling

Viscient Biosciences is Leveraging 3D Bioprinting for Drug Discovery

C2i a genomics SaaS product to detect traces of cancer raises 100M Series B

Global Transcriptomics Technologies Market Strategies 2025: Affymetrix Inc Thermo Fisher Scientific Agilent Technologies FHoffmann La Roche Ltd Illumina Inc

Tech Moves: Madrona grows investment team MicroVision Axon add board members and more

23andMe cofounders new startup Precisely brings genomics to India through Narayana partnerhsip

Genomics Market is expected to reach a revenue of 93318 million by 2023

How WhiteLab Genomics is using AI to aid gene and cell therapy development

African genomics startup 54gene raises 25M to expand precision medicine capabilities

LatAms Gent is working to enrich biotech with Brazilian genomic data

Karius raises 165 million for its liquid biopsy technology identifying diseases in a drop of blood

Human sequencing pioneer George Church wants to give you the power to sell your DNA on the blockchain

Welcome to the Desktop 3D Printing Revolution Part 2: Compounding Value

3D Printing Predictions for 2025: Software

Nobel laureate Jennifer Doudna shares her perspective on COVID19 and CRISPR